KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Tax Provisions (2016 - 2025)

Globus Medical's Tax Provisions history spans 15 years, with the latest figure at $28.6 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 1658.16% year-over-year to $28.6 million; the TTM value through Dec 2025 reached $67.2 million, up 278.85%, while the annual FY2025 figure was $67.2 million, 278.85% up from the prior year.
  • Tax Provisions reached $28.6 million in Q4 2025 per GMED's latest filing, up from $25.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $28.6 million in Q4 2025 to a low of -$14.7 million in Q2 2025.
  • Average Tax Provisions over 5 years is $10.6 million, with a median of $11.3 million recorded in 2021.
  • The largest YoY upside for Tax Provisions was 2057.39% in 2025 against a maximum downside of 192.74% in 2025.
  • A 5-year view of Tax Provisions shows it stood at $4.7 million in 2021, then soared by 155.21% to $12.1 million in 2022, then decreased by 17.35% to $10.0 million in 2023, then crashed by 118.45% to -$1.8 million in 2024, then skyrocketed by 1658.16% to $28.6 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Tax Provisions are $28.6 million (Q4 2025), $25.0 million (Q3 2025), and -$14.7 million (Q2 2025).